CD4 and glucose metabolism disease: With longer lives and more time on ART, the HIV-infected population in Africa is at increased risk of glucose metabolism disorders (GMDs) [3], and this risk will continue to broaden as African countries implement the 2013 WHO Treatment Guidelines to initiate ART at higher CD4+ T-cell counts (CD4 counts) [1].